Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Pillow ODM design company in Taiwan

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.China ergonomic pillow OEM supplier

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.ODM pillow factory in Thailand

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Soft-touch pillow OEM service in Vietnam

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.ODM pillow factory in China

Aging clocks, which measure biological age with precision, can deviate from chronological age due to environmental influences like smoking or diet. Researchers at the University of Cologne found that these clocks actually track increasing random cellular changes, suggesting that biological aging could be influenced by stochastic variations in processes like DNA methylation and gene activity. Aging clocks can accurately determine a person’s biological age, which can differ from their chronological age—the age calculated from their date of birth—due to environmental influences like diet or smoking. The precision of these clocks indicates that the aging process follows a program. Scientists David Meyer and Professor Dr. Björn Schumacher at CECAD, the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases of the University of Cologne, have now discovered that aging clocks actually measure the increase in stochastic changes in cells. The study was recently published published in Nature Aging. “Aging is triggered when the building blocks in our cells become damaged. Where this damage occurs is for the most part random. Our work combines the accuracy of aging clocks with the accumulation of entirely stochastic changes in our cells,” said Professor Schumacher. Fewer Checks, More Noise With increasing age, controlling the processes that occur in our cells becomes less effective, resulting in more stochastic results. This is particularly evident in the accumulation of stochastic changes in DNA methylation. Methylation refers to the chemical changes that affect DNA, the genome’s building blocks. These methylation processes are strictly regulated within the body. However, during the course of one’s life, random changes occur in the methylation patterns. The accumulation of variation is a highly accurate indicator of a person’s age. The loss of control over the cells and the increase in stochastic variation are not restricted to DNA methylation. Meyer and Schumacher demonstrate that the increase in stochastic variations also in gene activity can be used as an aging clock. “In principle it would be feasible to take this even further, allowing the stochastic variations in any process in the cell to predict age,” Schumacher said. According to the authors, it is above all crucial to ascertain if such aging clocks can show the success of interventions that slow the aging process or harmful factors that accelerate aging. Using the available datasets, the scientists showed that smoking increases the random changes in humans and that ‘anti-aging’ interventions such as lower calorie intake in mice reduce the variation in methylation patterns. They also showed that the stochastic noise is even reversible by means of reprogramming body cells to stem cells. The scientists compared human fibroblasts from the skin that were reprogrammed into stem cells and as a result of the reprogramming are rejuvenating. The high variation indicative of the age of the body cells was indeed reversed to the low stochastic noise of young stem cells. Meyer and Schumacher hope that their findings on the loss of regulation and the accumulating stochastic variations will lead to new interventions that can tackle the root cause of aging and may even lead to cellular rejuvenation. A target for such interventions could be repairing stochastic changes in DNA or improved control of gene expression. Reference: “Aging clocks based on accumulating stochastic variation” by David H. Meyer, and Björn Schumacher, 9 May 2024, Nature Aging. DOI: 10.1038/s43587-024-00619-x

New research indicates that pain experienced by newborns can lead to long-lasting genetic changes in their immune cells, intensifying pain responses as they grow, especially in females, highlighting the need for more specific treatments. Credit: SciTechDaily.com Research in mice indicates that focusing on genetic alterations in macrophage cells could be beneficial. Recent research increasingly suggests that the human body can retain memories of pain from injuries sustained in infancy, including life-saving surgeries, well into adolescence. These early experiences appear to change how a child’s pain response system develops at a genetic level, resulting in more intense reactions to pain later in life. Such changes also appear to occur more often among females. Now research led by experts at Cincinnati Children’s pinpoints how and where the genetic changes that create such long-lasting pain memory occur. According to their study, published in the journal Cell Reports, the key changes are occurring in developing macrophage cells—one of the major elements of the immune system. “Our experiments help to further confirm how pain memories affect female newborns for longer periods of time. Specifically, our data indicates that an epigenetic change (changes that occur post-birth vs inherited gene variations) occurs in macrophages after an early-life injury, which in turn promotes more-intense pain responses to other injuries that occur later in life,” says corresponding author Michael Jankowski, PhD, associate director of the Pediatric Pain Research Center at Cincinnati Children’s. Early-life injury can change how the body’s pain response system develops at a genetic level, leading to a pain “memory” that can affect response to injuries occurring years later, according to a study in Cell Reports published by experts at Cincinnati Children’s. Credit: Cell Reports and Cincinnati Children’s Adam Dourson, PhD, now working at Washington University in St. Louis, was the study’s lead author. The experiments show that male mice experiencing similar early-life injury show the same epigenetic changes but did not sustain the same long-term pain memory as females. Further testing also showed that changes, occurring in a gene called p75NTR, can be found in human macrophage cells. In female mice, the pain memory effects were detected for more than 100 days after the initial injury. Incisions caused stem cells in the bone marrow to generate macrophages that were “primed” to respond more intensely to injuries, which in turn increases pain. In humans, a similar timeframe would be roughly 10-15 years. “It was surprising to us to see how a single, local insult so dramatically altered the systemic macrophage epigenetic/transcriptomic landscape,” Jankowski says. This new understanding of neonatal pain memory underscores fundamental differences that exist between the genetic activity of a still-developing newborn immune system versus the mature system adults have. That means it will be complicated to determine how surgeons and care teams might go about adjusting how they manage recovery care for newborn and infant girls. “Simply changing pain medication doses may not be the answer. There’s always a balancing act between controlling pain and minimizing the possible harmful side effects of existing medications. Instead, our findings suggest there’s a need to develop more-specific, better-targeted treatments that could prevent the re-programming of macrophage cells in response to injury,” Jankowski says. Next steps More research is needed to use this new information to develop therapies to control immune “pain memories.” In this study, blocking the p75NTR receptor in young mice did blunt the ability of macrophages to communicate to sensory neurons and partially prevented prolonged pain-like behaviors. However, it remains unclear if similar methods can be safely used to target human macrophages. “Emerging technologies appear capable of specifically blocking the p75NTR receptor in macrophages, but it will require considerably more research before this approach would be ready for human clinical trials,” Jankowski says. Reference: “Macrophage memories of early-life injury drive neonatal nociceptive priming” by Adam J. Dourson, Adewale O. Fadaka, Anna M. Warshak, Aditi Paranjpe, Benjamin Weinhaus, Luis F. Queme, Megan C. Hofmann, Heather M. Evans, Omer A. Donmez, Carmy Forney, Matthew T. Weirauch, Leah C. Kottyan, Daniel Lucas, George S. Deepe and Michael P. Jankowski, 18 April 2024, Cell Reports. DOI: 10.1016/j.celrep.2024.114129 Funding for this study included multiple grants from the National Institutes of Health (R01NS105715, R01NS113965, F31NS122494, R01HL160614, P30 AR070549; an ARC award from Cincinnati Children’s and support from the Leukemia and Lymphoma Society.

An AI-designed “parent” organism (C shape; red) beside stem cells that have been compressed into a ball (“offspring”; green). Credit: Douglas Blackiston and Sam Kriegman AI-designed Xenobots reveal entirely new form of biological self-replication—promising for regenerative medicine. To persist, life must reproduce. Over billions of years, organisms have evolved many ways of replicating, from budding plants to sexual animals to invading viruses. Now scientists have discovered an entirely new form of biological reproduction — and applied their discovery to create the first-ever, self-replicating living robots. The same team that built the first living robots (“Xenobots,” assembled from frog cells — reported in 2020) has discovered that these computer-designed and hand-assembled organisms can swim out into their tiny dish, find single cells, gather hundreds of them together, and assemble “baby” Xenobots inside their Pac-Man-shaped “mouth” — that, a few days later, become new Xenobots that look and move just like themselves. And then these new Xenobots can go out, find cells, and build copies of themselves. Again and again. “With the right design — they will spontaneously self-replicate,” says Joshua Bongard, a computer scientist and robotics expert at the University of Vermont who co-led the new research. The results of the new research were published November 29, 2021, in the Proceedings of the National Academy of Sciences. Into the Unknown In a Xenopus laevis frog, these embryonic cells would develop into skin. “They would be sitting on the outside of a tadpole, keeping out pathogens and redistributing mucus,” says Michael Levin, a professor of biology and director of the Allen Discovery Center at Tufts University and co-leader of the new research. “But we’re putting them into a novel context. We’re giving them a chance to reimagine their multicellularity.” And what they imagine is something far different than skin. “People have thought for quite a long time that we’ve worked out all the ways that life can reproduce or replicate. But this is something that’s never been observed before,” says co-author Douglas Blackiston, the senior scientist at Tufts University who assembled the Xenobot “parents” and developed the biological portion of the new study. “We’ve discovered that there is this previously unknown space within organisms, or living systems, and it’s a vast space.” Josh Bongard “This is profound,” says Levin. “These cells have the genome of a frog, but, freed from becoming tadpoles, they use their collective intelligence, a plasticity, to do something astounding.” In earlier experiments, the scientists were amazed that Xenobots could be designed to achieve simple tasks. Now they are stunned that these biological objects—a computer-designed collection of cells — will spontaneously replicate. “We have the full, unaltered frog genome,” says Levin, “but it gave no hint that these cells can work together on this new task,” of gathering and then compressing separated cells into working self-copies. “These are frog cells replicating in a way that is very different from how frogs do it. No animal or plant known to science replicates in this way,” says Sam Kriegman, the lead author on the new study, who completed his PhD in Bongard’s lab at UVM and is now a post-doctoral researcher at Tuft’s Allen Center and Harvard University’s Wyss Institute for Biologically Inspired Engineering. AI-designed (C-shaped) organisms push loose stem cells (white) into piles as they move through their environment. Credit: Douglas Blackiston and Sam Kriegman On its own, the Xenobot parent, made of some 3,000 cells, forms a sphere. “These can make children but then the system normally dies out after that. It’s very hard, actually, to get the system to keep reproducing,” says Kriegman. But with an artificial intelligence program working on the Deep Green supercomputer cluster at UVM’s Vermont Advanced Computing Core, an evolutionary algorithm was able to test billions of body shapes in simulation — triangles, squares, pyramids, starfish — to find ones that allowed the cells to be more effective at the motion-based “kinematic” replication reported in the new research. “We asked the supercomputer at UVM to figure out how to adjust the shape of the initial parents, and the AI came up with some strange designs after months of chugging away, including one that resembled Pac-Man,” says Kriegman. “It’s very non-intuitive. It looks very simple, but it’s not something a human engineer would come up with. Why one tiny mouth? Why not five? We sent the results to Doug and he built these Pac-Man-shaped parent Xenobots. Then those parents built children, who built grandchildren, who built great-grandchildren, who built great-great-grandchildren.” In other words, the right design greatly extended the number of generations. An AI-designed, Pac-Man-shaped “parent” organism (in red) beside stem cells that have been compressed into a ball—the “offspring” (green). Credit: Douglas Blackiston and Sam Kriegman Kinematic replication is well-known at the level of molecules — but it has never been observed before at the scale of whole cells or organisms. “We’ve discovered that there is this previously unknown space within organisms, or living systems, and it’s a vast space,” says Bongard, a professor in UVM’s College of Engineering and Mathematical Sciences. “How do we then go about exploring that space? We found Xenobots that walk. We found Xenobots that swim. And now, in this study, we’ve found Xenobots that kinematically replicate. What else is out there?” Or, as the scientists write in the Proceedings of the National Academy of Sciences study: “life harbors surprising behaviors just below the surface, waiting to be uncovered.” As Pac-man-shaped Xenobot “parents” move around their environment, they collect loose stem cells in their “mouths” that, over time, aggregate to create “offspring” Xenobots that develop to look just like their creators. Credit: Doug Blackiston and Sam Kriegman Responding to Risk Some people may find this exhilarating. Others may react with concern, or even terror, to the notion of a self-replicating biotechnology. For the team of scientists, the goal is deeper understanding. “We are working to understand this property: replication. The world and technologies are rapidly changing. It’s important, for society as a whole, that we study and understand how this works,” says Bongard. These millimeter-sized living machines, entirely contained in a laboratory, easily extinguished, and vetted by federal, state, and institutional ethics experts, “are not what keep me awake at night. What presents risk is the next pandemic; accelerating ecosystem damage from pollution; intensifying threats from climate change,” says UVM’s Bongard. “This is an ideal system in which to study self-replicating systems. We have a moral imperative to understand the conditions under which we can control it, direct it, douse it, exaggerate it.” Xenobots are an invention of and collaborative research effort by (from left): Josh Bongard, University of Vermont; Michael Levin, Tufts University and the Wyss Institute at Harvard University; Douglas Blackiston, Tufts University; and Sam Kriegman, Tufts University and the Wyss Institute at Harvard University. Credit: Tufts and ICDO Bongard points to the COVID epidemic and the hunt for a vaccine. “The speed at which we can produce solutions matters deeply. If we can develop technologies, learning from Xenobots, where we can quickly tell the AI,: ‘We need a biological tool that does X and Y and suppresses Z,’ —that could be very beneficial. Today, that takes an exceedingly long time.” The team aims to accelerate how quickly people can go from identifying a problem to generating solutions—”like deploying living machines to pull microplastics out of waterways or build new medicines,” Bongard says. “We need to create technological solutions that grow at the same rate as the challenges we face,” Bongard says. And the team sees promise in the research for advancements toward regenerative medicine. “If we knew how to tell collections of cells to do what we wanted them to do, ultimately, that’s regenerative medicine—that’s the solution to traumatic injury, birth defects, cancer, and aging,” says Levin. “All of these different problems are here because we don’t know how to predict and control what groups of cells are going to build. Xenobots are a new platform for teaching us.” Reference: “Kinematic self-replication in reconfigurable organisms” by Sam Kriegman, Douglas Blackiston, Michael Levin, and Josh Bongard, 29 November 2021, Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.2112672118

DVDV1551RTWW78V